Current Chemical Genomics and Translational Medicine
2012, 6 : 55-71Published online 2012 October 5. DOI: 10.2174/1875397301206010055
Publisher ID: CCGTM-6-55
RESEARCH ARTICLE
Development of a Dehalogenase-Based Protein Fusion Tag Capable of Rapid, Selective and Covalent Attachment to Customizable Ligands
2 Promega Biosciences Incorporated, San Luis Obispo, CA, USA
3 Thermo Fisher Scientific, Life Science Research-Cellomics, Pittsburg, PA, USA
4 Cellular Dynamics International, Madison, WI, USA
5 GenScript USA Incorporated, Piscataway, NJ, USA
6 Gas Technology Institute, Des Plaines, IL, USA
* Address correspondence to this author at the Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, USA; Tel: 608-274-1181; Fax: 608-298-4818; E-mail: lance.encell@promega.com
ABSTRACT
Our fundamental understanding of proteins and their biological significance has been enhanced by genetic fusion tags, as they provide a convenient method for introducing unique properties to proteins so that they can be examinedin isolation. Commonly used tags satisfy many of the requirements for applications relating to the detection and isolation of proteins from complex samples. However, their utility at low concentration becomes compromised if the binding affinity for a detection or capture reagent is not adequate to produce a stable interaction. Here, we describe HaloTag® (HT7), a genetic fusion tag based on a modified haloalkane dehalogenase designed and engineered to overcome the limitation of affinity tags by forming a high affinity, covalent attachment to a binding ligand. HT7 and its ligand have additional desirable features. The tag is relatively small, monomeric, and structurally compatible with fusion partners, while the ligand is specific, chemically simple, and amenable to modular synthetic design. Taken together, the design features and molecular evolution of HT7 have resulted in a superior alternative to common tags for the overexpression, detection, and isolation of target proteins.